{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:24:10Z","timestamp":1783131850741,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572785"],"award-info":[{"award-number":["82572785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actbio.2026.04.045","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:16:08Z","timestamp":1777043768000},"page":"258-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A neuraminidase-functionalized injectable hydrogel depletes sialic acid to disrupt the tumor-osteoclast cycle and suppress breast cancer bone metastasis"],"prefix":"10.1016","volume":"217","author":[{"given":"Yao","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7576-0933","authenticated-orcid":false,"given":"Ziyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiulin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4724-9180","authenticated-orcid":false,"given":"Qijie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.actbio.2026.04.045_bib0001","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.actbio.2026.04.045_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202100536","article-title":"Scaffold 3D-printed from metallic nanoparticles-containing ink simultaneously eradicates tumor and repairs tumor-associated bone defects","volume":"5","author":"Lin","year":"2021","journal-title":"Small. Methods"},{"issue":"17","key":"10.1016\/j.actbio.2026.04.045_bib0003","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1158\/1078-0432.CCR-11-3310","article-title":"Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid","volume":"18","author":"Martin","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.actbio.2026.04.045_bib0004","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41565-024-01613-5","article-title":"Targeting initial tumour-osteoclast spatiotemporal interaction to prevent bone metastasis","volume":"19","author":"Gu","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.045_bib0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.045_bib0006","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","article-title":"The bone microenvironment invigorates metastatic seeds for further dissemination","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.actbio.2026.04.045_bib0007","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.devcel.2021.03.008","article-title":"The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells","volume":"56","author":"Bado","year":"2021","journal-title":"Dev. Cell"},{"issue":"8","key":"10.1016\/j.actbio.2026.04.045_bib0008","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamaoncol.2021.1854","article-title":"Prognosis of patients with early breast cancer receiving 5 years vs 2 years of adjuvant bisphosphonate treatment: a phase 3 randomized clinical trial","volume":"7","author":"Friedl","year":"2021","journal-title":"JAMa Oncol."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.045_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"issue":"13","key":"10.1016\/j.actbio.2026.04.045_bib0010","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.238840","article-title":"EGFR activation attenuates the mechanical threshold for integrin tension and focal adhesion formation","volume":"133","author":"Rao","year":"2020","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.045_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101726","article-title":"ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion","volume":"298","author":"Rao","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2026.04.045_bib0012","article-title":"Polysialic acid in the immune system","volume":"12","author":"Villanueva-Cabello","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.045_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bjc.1980.101","article-title":"Serum sialic acid and CEA concentrations in human breast cancer","volume":"41","author":"Hogan-Ryan","year":"1980","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.045_bib0014","first-page":"1365","article-title":"Differential expression of the \u03b12,3-sialic acid residues in breast cancer is associated with metastatic potential","volume":"25","author":"Cui","year":"2011","journal-title":"Oncol. Rep."},{"issue":"11","key":"10.1016\/j.actbio.2026.04.045_bib0015","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41417-022-00485-y","article-title":"Extracellular sialyltransferase ST6 GAL1 in breast tumor cell growth and invasiveness","volume":"29","author":"Hait","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.045_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-1-3","article-title":"ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function","volume":"1","author":"Christie","year":"2008","journal-title":"J. Ovarian. Res."},{"issue":"35","key":"10.1016\/j.actbio.2026.04.045_bib0017","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/s41388-021-01955-7","article-title":"NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2026.04.045_bib0018","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014126","article-title":"Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells","volume":"296","author":"Britain","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"669","key":"10.1016\/j.actbio.2026.04.045_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.045_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41551-024-01202-w","article-title":"Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager","volume":"8","author":"Yang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.045_bib0021","article-title":"Osteoclast-derived apoptotic bodies inhibit naive CD8(+) T cell activation via Siglec15, promoting breast cancer secondary metastasis","volume":"4","author":"Wu","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"16","key":"10.1016\/j.actbio.2026.04.045_bib0022","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.045_bib0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone metastasis: the importance of the neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.045_bib0024","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312929121","article-title":"Siglec-15\/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis","volume":"121","author":"Wang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.actbio.2026.04.045_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202415895","article-title":"Trifunctional sialylation-based SF-ZIF@NA hydrogel for selective osteoclast inhibition and enhanced bone-vessel regeneration in osteoporotic bone defects","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.045_bib0026","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jcp.30654","article-title":"Molecular structure, expression, and the emerging role of Siglec-15 in skeletal biology and cancer","volume":"237","author":"Rashid","year":"2022","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.045_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41413-021-00161-1","article-title":"An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP(+) mononuclear cells and PDGF-BB secretion","volume":"9","author":"Zhen","year":"2021","journal-title":"Bone Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.045_bib0028","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.7150\/thno.119200","article-title":"Fibroblast-derived NEU1 as a therapeutic target for improving cortical bone integrity and fracture healing","volume":"16","author":"Wu","year":"2026","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.045_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41413-022-00186-0","article-title":"Sialylation of TLR2 initiates osteoclast fusion","volume":"10","author":"Dou","year":"2022","journal-title":"Bone Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.045_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2007.03.016","article-title":"Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis","volume":"41","author":"Takahata","year":"2007","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.actbio.2026.04.045_bib0031","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1535-7163.MCT-13-0279","article-title":"Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth","volume":"12","author":"B\u00fcll","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.045_bib0032","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2004.10.010","article-title":"Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids","volume":"96","author":"Hsu","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"26","key":"10.1016\/j.actbio.2026.04.045_bib0033","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107424118","article-title":"Siglecs-7\/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity","volume":"118","author":"Ibarlucea-Benitez","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.045_bib0034","first-page":"739","article-title":"High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy","volume":"7","author":"He","year":"2021","journal-title":"J. Clin. Transl. Res."},{"issue":"23","key":"10.1016\/j.actbio.2026.04.045_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235840","article-title":"Insights into the role of sialylation in cancer metastasis, immunity, and therapeutic opportunity","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.045_bib0036","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3892\/or.2016.5180","article-title":"ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules","volume":"36","author":"Cui","year":"2016","journal-title":"Oncol. Rep."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:02:59Z","timestamp":1783130579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126002667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S1742706126002667"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.045","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A neuraminidase-functionalized injectable hydrogel depletes sialic acid to disrupt the tumor-osteoclast cycle and suppress breast cancer bone metastasis","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}